To test if the protection afforded by anti-TLR4 or anti-heme therapies was due to protection against bacterial pneumonia infection per se, rather than storage lesion plus bacterial pneumonia, mice were infected with PAK in the absence of any trauma, hemorrhage, or resuscitation. The gene discussed is TLR4; the disease is bacterial pneumonia.